Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab

Details 詳細情報について

• CRID

  1362825895808734848

• DOI

  10.1007/s10620-015-3581-4

• ISSN

  15732568

  01632116

• Web Site

  http://link.springer.com/content/pdf/10.1007/s10620-015-3581-4.pdf

  http://link.springer.com/article/10.1007/s10620-015-3581-4/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s10620-015-3581-4

• Data Source

  • Crossref